Latest News in the Life Sciences Industry
PR Newswire Association LLC.
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
29 Jul 2026
GlobeNewswire
RECORDATI: SOLID MOMENTUM OF THE GROUP CONTINUES FIRST HALF 2026. NET REVENUE +6.6%, EBITDA +8.8%, ADJUSTED NET INCOME +6.7%
28 Jul 2026
GlobeNewswire
Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026
27 Jul 2026
GlobeNewswire
Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
27 Jul 2026
GlobeNewswire
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
24 Jul 2026
GlobeNewswire
Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models
24 Jul 2026
GlobeNewswire
NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
24 Jul 2026
GlobeNewswire
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
23 Jul 2026
GlobeNewswire
Invitation to Idorsia's HY 2026 Financial Reporting webcast and conference call
23 Jul 2026
GlobeNewswire
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc
23 Jul 2026
GlobeNewswire
Publication in Clinical Reviews in Allergy & Immunology Summarizes Decades of Evidence Supporting Bradykinin B2 Receptor as a Validated Therapeutic Target in Bradykinin-Mediated Angioedema
22 Jul 2026
GlobeNewswire
Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health
22 Jul 2026
PR Newswire Association LLC.
Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma
22 Jul 2026
GlobeNewswire
Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance
22 Jul 2026
GlobeNewswire
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
21 Jul 2026
PR Newswire Association LLC.
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026
21 Jul 2026
PR Newswire Association LLC.
ABILITY Neurotech Announces First-In-Human Testing for Novel Brain-Computer Interface Technology
21 Jul 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan